| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/08/1994 | US5292766 Method for improving primary memory and/or learning |
| 03/08/1994 | US5292765 Neuroprotection by indolactam V and derivatives thereof |
| 03/08/1994 | US5292761 Piperidine, tetrahydropyridine and pyrrolidine compounds |
| 03/08/1994 | US5292753 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 03/08/1994 | US5292749 Antimuscarinic bronchodilators |
| 03/08/1994 | US5292745 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 03/08/1994 | US5292740 Sulfonamides |
| 03/08/1994 | US5292739 Aryl(or heteroaryl) piperazinylalkylazole derivatives, their preparation and their application as medicaments |
| 03/08/1994 | US5292735 Cyclic amide derivatives |
| 03/08/1994 | US5292732 Pyrrolopyrazine derivatives |
| 03/08/1994 | US5292730 Modulation of immune system with Δ5-androstenes |
| 03/08/1994 | US5292512 Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product |
| 03/08/1994 | CA1327577C 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)- pyrimidinedione derivatives, their preparation and their application in therapy |
| 03/08/1994 | CA1327575C 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation |
| 03/08/1994 | CA1327572C Imidazodiazepine derivatives |
| 03/04/1994 | CA2484248A1 Excitatory amino acid receptor antagonists |
| 03/03/1994 | WO1994004698A1 Novel protein and gene coding for the same |
| 03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
| 03/03/1994 | WO1994004552A1 Opioid receptor genes |
| 03/03/1994 | WO1994004532A1 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 03/03/1994 | WO1994004531A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 03/03/1994 | WO1994004496A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 03/03/1994 | WO1994004494A1 Tachykinin antagonists |
| 03/03/1994 | WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism |
| 03/03/1994 | WO1994004138A1 Sustained release tablets containing bupropion |
| 03/03/1994 | WO1993023035A3 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
| 03/03/1994 | CA2142305A1 Opioid receptor genes |
| 03/03/1994 | CA2140640A1 Tachykinin antagonists |
| 03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
| 03/02/1994 | EP0585116A1 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0584903A1 Process for preparing aryl piperazinyl-heterocyclic compounds |
| 03/02/1994 | EP0584487A2 4,5-Dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584340A1 Diagnosis and treatment of various neuralgias |
| 03/02/1994 | EP0584290A1 Endothelin antagonists |
| 03/02/1994 | EP0584285A1 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 03/02/1994 | EP0584247A1 Compositons for the treatment of chronic fatigue syndrome |
| 03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 03/02/1994 | EP0584192A1 Prodrug esters of phenolic 2-piperidino-1-alkanols |
| 03/02/1994 | EP0584108A1 Pharmaceutical composition comprising ibuprofen salt |
| 03/02/1994 | EP0584091A1 Benzopyranones, methods of manufacture and use thereof. |
| 03/02/1994 | EP0584088A1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
| 03/02/1994 | EP0508988B1 Muscarinic receptor antagonists |
| 03/02/1994 | EP0266419B1 Fibrinolytic composition |
| 03/02/1994 | CN1083074A Peptide compounds |
| 03/02/1994 | CN1083066A Novel thienothiazine derivatives, process for their preparation and their use |
| 03/02/1994 | CN1083061A Process for preparation aryl piperazinyl-heterocyclic compounds |
| 03/02/1994 | CN1023895C Preparation method for N-aralkyl piperidinemethanol derivatives |
| 03/01/1994 | US5290951 Intermediates useful in preparing propenone oxime ethers |
| 03/01/1994 | US5290939 Process for the manufacture of brofaromine and analogs thereof |
| 03/01/1994 | US5290816 Composition of resiniferatoxin and analogues thereof to cause sensory afferent C-Fiber and thermoregulatory desensitization |
| 03/01/1994 | US5290802 Analgesics, antiinflammatory agents, antiarthritic agents, prostaglandin, enzyme and interleukin inhibitors |
| 03/01/1994 | CA1327364C 1-¬(diarylmethoxy)alkyl|pyrrolidines and piperidines; process for preparing the same and drugs containing them |
| 03/01/1994 | CA1327315C Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 02/27/1994 | CA2104626A1 Pharmaceutical compounds |
| 02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/25/1994 | CA2104653A1 4,5-dihydro-4-oxo-pyrrolo [1,2-a] quinoxalinones] and corresponding aza analogs and a process for their preparation |
| 02/24/1994 | CA2104501A1 Di- and triazinediones |
| 02/23/1994 | EP0583665A2 Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis |
| 02/23/1994 | EP0583421A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/23/1994 | EP0583408A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/23/1994 | EP0583322A1 Antiserotonines, prepartion thereof and medicaments containing them |
| 02/23/1994 | EP0583271A1 Arylmorpholine, preparation and use |
| 02/23/1994 | CN1082545A Imidazopyridine |
| 02/23/1994 | CN1082543A 吲哚衍生物 Indole derivatives |
| 02/23/1994 | CN1082542A 苯并咪唑衍生物 Benzimidazole derivatives |
| 02/22/1994 | US5288863 Process for the preparation of high-purity 1-(3-chloro-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine |
| 02/22/1994 | US5288751 [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
| 02/22/1994 | US5288749 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 02/22/1994 | US5288748 Centrally acting 6,7,8,9-tetrahydro-3H-benz(e)indole heterocyclics |
| 02/22/1994 | US5288730 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 02/22/1994 | US5288724 Antiserotonine agents, hypotensive agents, antidepressants |
| 02/22/1994 | US5288719 2-,3-,8-and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating osteoporosis |
| 02/22/1994 | CA1327202C Substituted 1,3,4,9-tetrahydropyrano ¬3,4-b|indole-1-acetic acids |
| 02/22/1994 | CA1327163C Anxiolytically active piperazine derivatives |
| 02/17/1994 | WO1994003644A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | WO1994003469A1 New derivatives of neuraminic acid |
| 02/17/1994 | WO1994003456A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties |
| 02/17/1994 | WO1994003455A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 02/17/1994 | WO1994003447A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003445A1 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists |
| 02/17/1994 | WO1994003444A1 Amide derivatives |
| 02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003436A1 Novel piprazine carboxamides |
| 02/17/1994 | WO1994003430A1 Novel pyridyl- and pyrimidylpiperazine derivatives |
| 02/17/1994 | WO1994003426A1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists |
| 02/17/1994 | WO1994003200A1 Morphogen-induced nerve regeneration and repair |
| 02/17/1994 | WO1994003189A1 Therapeutic methods using caesium ions |
| 02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | WO1994003176A1 Treatment of alzheimer's disease and modulation of immune system with δ5-androstenes |
| 02/17/1994 | WO1994003161A1 Controlled release morphine preparation |
| 02/17/1994 | WO1994003158A1 Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 02/17/1994 | WO1994003059A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 02/17/1994 | CA2142185A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | CA2141810A1 Amide derivatives |
| 02/17/1994 | CA2141791A1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists |
| 02/17/1994 | CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |